1.湯夢彬；陳守堅；李之微；溫增光；孫曉光；賴義傑。灰指甲。家庭醫學與基層醫療，頁377-381，2011。
2.徐文媛，灰指甲 不要污辱我的美！ 常春月刊，頁86-89， 2009。3.王貞乃 ，還指甲本色--談灰指甲的治療 。健康世界，頁47-49，1998。4.凌關庭，「食品添加劑手冊第二版」，化學工業出版社，北京(1986)。
5.傅筱芬，｢含水維他命 - E 的抗水性硬膠囊配方及品管方法開發｣，碩士論文，朝陽科技大學應用化學系，台中 ( 2007 )。6.region.Baran R, Feuilhade M, Combernale P, Datry A, Goettmann S, Pietrini P, Viguie C, Badillet G, Larnier C, Czernielewski J.A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix;142(6):1177-83, 2000.
7. Jean-Paul L. Marty ; Amorolfine nail lacquer: a novel formulation , 10 March 2000.
8.Rigopoulos D, Katoulis AC, Ioannides D, Georgala S, Kalogeromitros D, Bolbasis I, Karistinou A, Christofidou E, Polydorou D, Balkou P, Fragouli E,Katsambas AD.A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. 149(1):151-6 ,2003.
9.Asian Jouranl oh Pharmaceutical and Health Sciences , Determination and Validation of RP – HPLC Method for Amorolfine Hyrochloroide in Pharmaceutical Dosage Forms.
10.Baran R.Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. 145 Suppl 60:15-9, 2001.
11.朱思穎 ; 李定達 ，指甲病變：診斷系統性疾病的線索 。臨床醫學，，頁274-280，2010。
12.邱義人。指甲油配製。化工技術，頁36-3，1986。13.連美華；黃琴喨；黃明權；鄒玫君。指甲油中甲醇及氯仿含量之調查，藥物食品檢驗局調查研究年報，頁32-35， 2007。14.Chu, H. L., Shaw, J. F., “Biochemical characterization of isozymesof bighead shrimp tyrosinase,” J. Chinese. Agri. Chem. Soc., No.27, pp. 360-372 (1989).
15.Chang, L. C., Application of cosmetics Inspecting, FayfarPublishing Co., Ltd, Taiwan, pp. 243-246 (1998).
16.維基百科，胭脂紅。http://zh.wikipedia.org/zh-hk/%E8%83%AD%E8%84%82%E7%B4%85
17.賴耿陽，印染色糊調液法－鹽基性染料5.3.4，P218。
18.Anupama B, Jagathi V, Vishwanadh A, Rajesh V；Determination and Validation of RP-HPLC Method for Amorolfine Hydrochloride in Pharmaceutical Dosage Forms. Asian Journal of Pharmaceutical and Health Sciences.
19.王成剛 余立；HPLC法測定鹽酸阿莫羅芬搽劑的含量。中國抗生素雜誌研究簡報，5卷，第3期， 2000。
20.Baran R, Feuilhade M, Combernale P, Datry A, Goettmann S, Pietrini P, Viguie C, Badillet G, Larnier C, A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Czernielewski J. 142(6):1177-83, 2000.
21. Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. 145 Suppl 60:21-6, 2001.
22. Schaller M, Borelli C, Berger U, Walker B, Schmidt S, Weindl G, Jackel A. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. 47(7):753-8, 2009.
23. Li RY, Wan Z, Wang AP, Shen YN, Lu CM, Li M, Xi LY, Liu WD, Zeng FQ. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China. 47(9-10):402-6, 2004.
24.The Royal Pharmaceutical Society of Great Britain Amorolfine Information Doctor Fungus Information on Amorolfine.
25. D. Rigopoulos, A.C. Katoulis, D. Ioannides, S. Georgala, D. Kalogeromitros, I. Bolbasis, A. Karistinou, E. Christofidou, D. Polydorou, P. Balkou, E. Fragouli and A.D.Katsambas;"The British Journal of Dermatology"; A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis, 2003.
26.Malini Haria and Harriet M."Drugs; Amorolfine: A Review of its Pharmacological Properties and Therapeutic Potential in the Treatment of Onychomycosis and Other Superficial Fungal Infections; Bryson; January 1995.